Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013, Article ID 615189, 3 pages
Case Report

A Case of Erythrocytosis in a Patient Treated with an Aromatase Inhibitor for Breast Cancer

Hematology Division, Department of Medicine, The Ottawa Hospital, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6

Received 2 September 2013; Accepted 22 September 2013

Academic Editors: U. Dasgupta, C. Imai, K. Khair, and D. Rund

Copyright © 2013 Abhinav Iyengar and Dawn Sheppard. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. L. Semenza and G. L. Wang, “A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation,” Molecular and Cellular Biology, vol. 12, no. 12, pp. 5447–5454, 1992. View at Google Scholar · View at Scopus
  2. B. A. Witthuhn, F. W. Quelle, O. Silvennoinen et al., “JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin,” Cell, vol. 74, no. 2, pp. 227–236, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Scott, W. Tong, R. L. Levine et al., “JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis,” The New England Journal of Medicine, vol. 356, no. 5, pp. 459–468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. D. T. Diaz-Thomas et al., “Too much of a good thing: polycythemia and aromatase inhibitors,” 2010, AAP Capital Letters,
  5. E. Bachman, R. Feng, T. Travison et al., “Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 10, pp. 4743–4747, 2010. View at Publisher · View at Google Scholar · View at Scopus